MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. This is where exploring cannabis therapy for chronic conditions enters the picture as a promising alternative.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

LifeCannMD

JANUARY 31, 2025

Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.

Conditions 97

Conditions Research and Development Treatment Patients 97

Cannabis Law Report

SEPTEMBER 2, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Cannabis is a really special case.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. Patient intake form. I felt free from my ailment.

Marijuana 189

Marijuana Patients Conditions Treatment 189

LifeCannMD

MARCH 31, 2025

“I’ve watched patients walk through my door carrying not just physical pain, but the weight of cultural stigma, family concerns, and years of medical dismissal,” Dr. Fandino-Sende shares. That’s about reconnection to what makes life worth living,” he explains, pausing to show a patient how to adjust their dosage.

Treatment 80

Treatment Chronic Pain History Conditions 80

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Pennsylvania-based Groff North America is one of the companies that is getting a green light to experiment with the plant. territories.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

FloridaMarijuana.net

JULY 5, 2018

As with all medicinal interventions, strains may affect each person and medical condition differently. Be sure to speak with your medical marijuana physician about their recommendations based on your individual needs and medical conditions. Patients often report feeling relief almost immediately. Super Sour Diesel/Sativa.

Strains 189

Strains Chronic Pain Indica Hybrid 189

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Certain conditions require more cannabinoids than others. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation.

Marijuana 278

Marijuana Dispensary Patients Retail 278

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 10, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. About MyMD Pharmaceuticals, Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

CannaMD

NOVEMBER 8, 2021

In recognition of this information, a significant but still limited number of Parkinson’s patients have turned to cannabis as a complementary therapy to traditional pharmaceutical options. A survey of current […].

Patients 105

Patients Therapy Pharmaceutical Marijuana 105

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. These symptoms can be unbearable for both patients and their caregivers.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

FloridaMarijuana.net

AUGUST 9, 2018

Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. This means that often pharmaceutical medications are experimental. Medical marijuana can contribute to a patient’s overall health.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

Veriheal

APRIL 7, 2022

As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . In a survey of 5,481 MS patients, 47% considered using MMJ, but only 20% spoke with their physician about it. Of the surveyed patients, only 26% reported using it for symptoms.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 235

Access Marijuana Treatment Legislation 235

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. Neuropathy, or nerve damage, effects over 30 million Americans. Sensitivity to touch or temperature.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.

Policy 187

Policy Patients Education Legislation 187

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89

Access Patients Pharmaceutical Education 89

FloridaMarijuana.net

OCTOBER 5, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. The post Terpene Spotlight: Phytol appeared first on.

Terpenes 181

Terpenes Strains Oil Medicine 181

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. In response, veterinarians and others concerned for patient safety promoted a change in state law. Gary Richter, a Project CBD contributing writer, is an Oakland-based veterinarian.

Pets 218

Pets Legalization Hemp Extraction 218

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 220

Legislation Decriminalization Hemp Patients 220

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. What is IBS?

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. There are a variety of treatment options to help patients cope with and heal from anxiety disorders.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Veriheal

SEPTEMBER 7, 2022

’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C. A Temporary Triumph for Medical Cannabis Patients. The State of Patients’ Rights and Access in America Today.

Patients 98

Patients Programs Access Treatment 98

FloridaMarijuana.net

OCTOBER 11, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. As with all medicinal interventions, terpenes and strains may affect each person and medical condition differently. These descriptions are meant as a guide.

Terpenes 172

Terpenes Strains Medicine Oil 172

Canna Law Blog

MARCH 25, 2025

Follow strict patient verification and dispensing rules. Can businesses cultivate cannabis for pharmaceutical research? Under the Therapeutic Goods Act and respective State/Territory guidelines, advertising medicinal cannabis directly to patients can violate advertising laws. The conditions of the relevant licenses and permits.

Research and Development 88

Research and Development Medicine Compliance Compliance 88

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Current TNF-a inhibitors available today, while effective, come with an array of adverse effects and concerns for patients,” said Adam Kaplin, M.D., About MyMD Pharmaceuticals, Inc. Company plans to initiate Phase II trial with a leading academic institution.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

CannaMD

FEBRUARY 19, 2020

Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. And in recent years, a spate of new research has added scientific credibility to the success stories of patients who have used medical marijuana to relieve their symptoms.

CBD 108

CBD Pharmaceutical Research and Development Conditions 108